Atjaunināt sīkdatņu piekrišanu

E-grāmata: Constitutive Activity in Receptors and Other Proteins, Part A

Volume editor (The Salk Institute, La Jolla, CA, USA)
  • Formāts: EPUB+DRM
  • Sērija : Methods in Enzymology
  • Izdošanas datums: 26-Nov-2010
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780123812995
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 153,85 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Sērija : Methods in Enzymology
  • Izdošanas datums: 26-Nov-2010
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780123812995
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins. The chapters written by expert authors who are leaders in the field, provide hints and tricks not available in primary research publications.It is extensively referenced, with useful figures and tables throughout the volume.

  • Expert authors who are leaders in the field
  • Extensively referenced and useful figures and tables
  • Provides hints and tricks to facilitate reproduction of methods


This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins. The chapters written by expert authors who are leaders in the field, provide hints and tricks not available in primary research publications.It is extensively referenced, with useful figures and tables throughout the volume.

A. Expert authors who are leaders in the field

B. Extensively referenced and useful figures and tables

C. Provides hints and tricks to facilitate reproduction of methods

Papildus informācija

This volume of Methods in Enzymology covers the current methodology for the detection and assessment of constitutively active proteins.
Contributors xv
Preface xxv
Volumes in Series xvii
Section I Identification and Measurement of Constitutive Activity
1
1 Constitutive Activity at the Cannabinoid CB1 Receptor and Behavioral Responses
3(28)
Katherine E. Hanlon
Todd W. Vanderah
1 Introduction
4(2)
2 Modifying CB1 Activity
6(6)
3 Behavioral Models
12(14)
References
26(5)
2 Detecting Constitutive Activity and Protean Agonism at Cannabinoid-2 Receptor
31(22)
Massimiliano Beltramo
Rossella Brusa
Isabella Mancini
Paola Scandroglio
1 Introduction
32(2)
2 General Considerations
34(1)
3 Evaluation of Constitutive Activity Using GTPγS Assay
35(4)
4 Evaluation of Constitutive Activity Using cAMP Assay
39(3)
5 Evaluation of Constitutive Activity Using RT-CES
42(4)
6 Evaluation of Protean Agonism with cAMP Assay
46(2)
7 Comparison of the Methods
48(1)
References
49(4)
3 Modulation of the Constitutive Activity of the Ghrelin Receptor by Use of Pharmacological Tools and Mutagenesis
53(22)
Jacek Mokrosinski
Birgitte Holst
1 Introduction
54(1)
2 The Ghrelin Receptor and its Constitutive Activity
55(2)
3 Structural Basis of Constitutive Activity
57(4)
4 Residues Responsible for the Inverse Agonism and Efficacy Swap
61(4)
5 Physiological Relevance of Constitutive Activity
65(1)
6 Experimental Procedures
66(3)
References
69(6)
4 Assessment of Constitutive Activity and Internalization of GPR54 (KISS1-R)
75(20)
Macarena Pampillo
Andy V. Babwah
1 Introduction
76(1)
2 Materials
77(2)
3 Methods
79(12)
Acknowledgment
91(1)
References
92(3)
5 Assessment of Constitutive Activity in E-Type Prostanoid Receptors
95(14)
Hiromichi Fujino
Toshihiko Murayama
John W. Regan
1 Introduction
96(1)
2 Assays Used to Assess EP3 Receptor Constitutive Activity
97(8)
3 Assays Used to Assess EP4 Receptor Constitutive Activity
105(2)
References
107(2)
6 α1D-Adrenergic Receptors: Constitutive Activity and Reduced Expression at the Plasma Membrane
109(18)
J. Adolfo Garcia-Sainz
M. Teresa Romero-Avila
Luz del Carmen Medina
1 Introduction
110(1)
2 Methods
111(3)
3 Constitutive Activity
114(3)
4 Plasma Membrane α1D-Adrenergic Receptors
117(2)
5 Possible Physiological Implications
119(2)
Acknowledgments
121(1)
References
121(6)
7 Constitutive Activity of the Histamine H1 Receptor
127(22)
Saskia Nijmeijer
Rob Leurs
Henry F. Vischer
1 Introduction
128(5)
2 Methods to Study Constitutive H1R Signaling
133(9)
3 Constitutive Activity as Tool to Elucidate Receptor Activation and Crosstalk
142(2)
4 Conclusion
144(1)
Acknowledgments
144(1)
References
145(4)
8 Constitutive Activity of Somatostatin Receptor Subtypes
149(16)
Anat Ben-Shlomo
Kolja Wawrowsky
Shlomo Melmed
1 Introduction
150(1)
2 Choosing Cells to be Studied
151(1)
3 Modifying SSTR Density
152(11)
4 Summary
163(1)
References
163(2)
9 Assessment of Homologous Internalization of Constitutively Active N111G Mutant of AT1 Receptor
165(14)
Mohiuddin Ahmed Bhuiyan
Takafumi Nagatomo
1 Introduction
166(1)
2 Preparation of Receptor Plasmid and Protein
167(1)
3 Radioligand Binding Assay
168(2)
4 Inositol Phosphate Accumulation Assay
170(1)
5 Internalization Assay
171(2)
6 Western Blot Analysis
173(1)
7 Data Analysis
174(1)
8 Concluding Remark
175(1)
References
175(4)
10 Methods to Detect Cell Surface Expression and Constitutive Activity of GPR6
179(18)
Balakrishna M. Prasad
Bettye Hollins
Nevin A. Lambert
1 Introduction
180(1)
2 GPR6 is Expressed in Intracellular Compartments
180(7)
3 Comparison of the Cell Surface Protein Detection Methods
187(5)
4 Comparison of the Constitutive Gs-Activity Detection Methods
192(2)
5 Conclusions
194(1)
References
194(3)
11 β3-Adrenoceptor Agonists and (Antagonists as) Inverse Agonists: History, Perspective, Constitutive Activity, and Stereospecific Binding
197(34)
Maria Grazia Perrone
Antonio Scilimati
1 Introduction
198(3)
2 β3-Adrenoceptor
201(13)
3 Methodologies
214(10)
Acknowledgments
224(1)
References
225(6)
12 Constitutive Activity of the Lutropin Receptor and Its Allosteric Modulation by Receptor Heterodimerization
231(22)
Deborah L. Segaloff
1 Introduction
232(3)
2 General Principles for Quantifying Receptor Activation
235(4)
3 Modifying Cell Surface Expression Levels of Recombinant hLHR and Mutants Thereof
239(4)
4 Quantifying Cell Surface hLHR Expression
243(2)
5 Quantifying cAMP Production in Cells Expressing the hLHR
245(1)
6 Experimental Strategies for Characterizing the Attenuating Effects of a Signaling Inactive hLHR on a Coexpressed wt or CAM hLHR
246(4)
Acknowledgment
250(1)
References
250(3)
13 Assessing Constitutive Activity of Extracellular Calcium-Sensing Receptors in Vitro and in Bone
253(14)
Wenhan Chang
Melita Dvorak
Dolores Shoback
1 Introduction
254(4)
2 Materials and Methods
258(4)
3 Results
262(1)
4 Conclusions
263(2)
Acknowledgments
265(1)
References
265(2)
14 Constitutive Activity of Neural Melanocortin Receptors
267(14)
Ya-Xiong Tao
Hui Huang
Zhi-Qiang Wang
Fan Yang
Jessica N. Williams
Gregory V. Nikiforovich
1 Introduction
268(1)
2 Signaling Assay for the Neural Melanocortin Receptors
268(2)
3 Naturally Occuring Constitutively Active MC4R Mutants
270(3)
4 Inverse Agonism of AgRP at the MC3R
273(1)
5 Computational Modeling of the Constitutively Active MC4R Mutants
273(4)
Acknowledgments
277(1)
References
277(4)
15 Measurement of Constitutive Activity of BMP Type I Receptors
281(14)
David J. J. de Gorter
Maarten van Dinther
Peter ten Dijke
1 Introduction
281(3)
2 Determining ALK2 Constitutive Activity
284(5)
3 Determining the Effects of ALK2 Constitutive Activity on Osteoblast Differentiation
289(2)
4 Concluding Remarks
291(1)
Acknowledgments
292(1)
References
292(3)
16 Probing the Constitutive Activity Among Dopamine D1 and D5 Receptors and Their Mutants
295(34)
Bianca Plouffe
Jean-Philippe D'Aoust
Vincent Laquerre
Binhui Liang
Mario Tiberi
1 Introduction
296(3)
2 Design of Genetically Modified D1-Like Receptor Constructs and Cloning Strategy
299(2)
3 Transfection of D1R and D5R Expression Constructs in HEK293 Cells
301(2)
4 Radioligand-Binding Assays
303(2)
5 Whole Cell cAMP Assays
305(8)
6 Results Validating Experimental Approaches
313(11)
7 Concluding Remarks
324(2)
Acknowledgments
326(1)
References
327(2)
17 Identification of Gain-of-Function Variants of the Human Prolctin Receptor
329(28)
Vincent Goffin
Roman L. Bogorad
Philippe Touraine
1 Introduction
330(3)
2 Experimental Procedures
333(12)
3 Identification of Constitutive Activity: Results and Discussion
345(8)
4 Conclusions
353(1)
Acknowledgments
353(1)
References
353(4)
18 Investigations of Activated ACVR1/ALK2, a Bone Morphogenetic Protein Type I Receptor, That Causes Fibrodysplasia Ossificans Progressiva
357(18)
Frederick S. Kaplan
Petra Seemann
Julia Haupt
Meiqi Xu
Vitali Y. Lounev
Mary Mullins
Eileen M. Shore
1 Introduction
358(1)
2 Patient Methodologies
359(3)
3 Cellular Methodologies
362(4)
4 Tissue Methodologies
366(3)
5 In Vivo Methodologies
369(2)
Acknowledgments
371(1)
References
371(4)
19 Identification and Evaluation of Constitutively Active Thyroid Stimulating Hormone Receptor Mutations
375(22)
Joaquin Lado-Abeal
Leah R. Quisenberry
Isabel Castro-Piedras
1 Introduction
376(6)
2 TSHR Gene Mutational Screening
382(4)
3 Determination of TSHR Constitutive Activity In Vitro
386(2)
4 Measurement of TSHR Expression at Cell Surface by Flow Cytometry Analysis
388(1)
5 TSH-TSHR Binding Assays
389(2)
6 TSHR Phosphorylation Analysis
391(1)
Acknowledgments
392(1)
References
392(5)
20 Assessment of Constitutive Activity of a G Protein-Coupled Receptor, Cpr2, in Cryptococcus neoformans by Heterologous and Homologous Methods
397(16)
Chaoyang Xue
Yina Wang
Yen-Ping Hsueh
1 Introduction of Receptors and Constitutive Receptors
398(1)
2 Identification of Cpr2 as a Natural Occuring Constitutively Active Receptor
399(10)
3 Additional Constitutively Active Receptors Identified in Fungi
409(1)
Acknowledgments
409(1)
References
409(4)
21 In Vitro and In Vivo Assessment of Mu Opioid Receptor Constitutive Activity
413(32)
Edward J. Bilsky
Denise Giuvelis
Melissa D. Osborn
Christina M. Dersch
Heng Xu
Richard B. Rothman
1 Introduction
414(1)
2 Measuring Opioid Receptor Constitutive Activity in Vitro
415(10)
3 cAMP Quantification Assay in CHO Cells Expressing Cloned Opioid Receptors
425(5)
4 In Vivo Assessment of Antagonist Potency in Opioid Naive Subjects
430(5)
5 In Vivo Assessment of Antagonist Potency to Precipitate Withdrawal
435(5)
6 Summary
440(1)
Acknowledgments
441(1)
References
441(4)
22 Constitutively Active μ-Opioid Receptors
445(26)
Mark Connor
John Traynor
1 Introduction
446(1)
2 Methods for Measuring Constitutive Activity
447(18)
3 Conclusions
465(1)
Acknowledgments
465(1)
References
466(5)
23 Protein Kinase CK2 is a Constitutively Active Enzyme that Promotes Cell Survival: Strategies to Identify CK2 Substrates and Manipulate its Activity in Mammalian Cells
471(24)
Jacob P. Turowec
James S. Duncan
Ashley C. French
Laszlo Gyenis
Nicole A. St. Denis
Greg Vilk
David W. Litchfield
1 Introduction
472(2)
2 Purification of CK2 for In Vitro Studies
474(7)
3 Assays for CK2 Activity
481(4)
4 Modulation of CK2 in Mammalian Cells
485(6)
5 Conclusions
491(1)
Acknowledgments
491(1)
References
492(3)
24 Assessment of CK2 Constitutive Activity in Cancer Cells
495
Maria Ruzzene
Giovanni Di Maira
Kendra Tosoni
Lorenzo A. Pinna
1 Introduction
496(3)
2 Assay of CK2 in Crude Biological Samples
499(5)
3 In-Cell Assay of Endogenous CK2 Activity
504(2)
4 Identification/Validation of in Vivo CK2 Targets with Specific Inhibitors
506(5)
Acknowledgments
511(1)
References
511